BRIEF: Judge to hear motion arguments

Johnson and Johnson Baby Products Company will argue in favor of their motion for summary judgement, which, if granted, would dismiss the suit University Patent, Inc. brought against them in 1989 to secure a portion of the rights to Retin-A. "We believe that a strong argument can be made for dismissing U.P.I. now," said Johnson and Johnson attorney Ellen Martin yesterday. "If we do not succeed at this point, however, we will renew the motion later." U.P.I. has argued that since they possessed a patent licensing and servicing agreement with the University and the "miracle" acne drug was developed by Dermatology Professor Emeritus Albert Kligman at the University, they have a partial right to the patent. University Associate General Counsel said the outcome of the motion will not affect the University's standing in the case. -- Stephen Glass

Please note All comments are eligible for publication in The Daily Pennsylvanian.